| 1 |
Wang S, Zhou J, Yang J, Wang X, Chen X, Ji L, Yang L. Clinical features and prognostic factors of acute kidney injury caused by adult secondary hemophagocytic lymphohistiocytosis. J Nephrol. [DOI: 10.1007/s40620-021-01147-2] [Reference Citation Analysis]
|
| 2 |
Guerrero-hue M, Rubio-navarro A, Sevillano Á, Yuste C, Gutiérrez E, Palomino-antolín A, Román E, Praga M, Egido J, Moreno JA. Efectos adversos de la acumulación renal de hemoproteínas. Nuevas herramientas terapéuticas. Nefrología 2018;38:13-26. [DOI: 10.1016/j.nefro.2017.05.009] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
|
| 3 |
Dokouhaki P, van der Merwe D, Vats K, Said SM, D’agati VD, Nasr SH. Histiocytic Glomerulopathy Associated With Hemophagocytic Lymphohistiocytosis. Kidney Medicine 2021. [DOI: 10.1016/j.xkme.2021.10.009] [Reference Citation Analysis]
|
| 4 |
Hakamifard A, Mardani M, Gholipur-Shahraki T. Hemophagocytic lymphohistiocytosis presented with fever of unknown origin: A case study and literature review. Clin Case Rep 2021;9:2350-5. [PMID: 33936693 DOI: 10.1002/ccr3.4033] [Reference Citation Analysis]
|
| 5 |
Steffen CJ, Koch N, Eckardt KU, Amann K, Seelow E, Schreiber A. Hemophagocytic lymphohistiocytosis and thrombotic microangiopathy after parvovirus B19 infection and renal transplantation: a case report. BMC Nephrol 2021;22:337. [PMID: 34641801 DOI: 10.1186/s12882-021-02538-0] [Reference Citation Analysis]
|
| 6 |
Osti N, Beschin G, Goldin M, Guidolin L, Panero E, Sartori A, Parisi A, Cantini M, Pizzolo F, Olivieri O, Friso S. Case Report: Microangiopathic Hemolytic Anemia With Normal ADAMTS13 Activity. Front Med (Lausanne) 2021;8:589423. [PMID: 33738292 DOI: 10.3389/fmed.2021.589423] [Reference Citation Analysis]
|
| 7 |
Guo HY, Sun J, Su Y, Zhang Q, Hua R, Xia X, Fang D. Thrombotic microangiopathy led to acute kidney injury in an infant with hemophagocytic lymphohistiocytosis: A case report. Exp Ther Med 2021;21:396. [PMID: 33680118 DOI: 10.3892/etm.2021.9827] [Reference Citation Analysis]
|
| 8 |
Gloude NJ, Dandoy CE, Davies SM, Myers KC, Jordan MB, Marsh RA, Kumar A, Bleesing J, Teusink-Cross A, Jodele S. Thinking Beyond HLH: Clinical Features of Patients with Concurrent Presentation of Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy. J Clin Immunol 2020;40:699-707. [PMID: 32447592 DOI: 10.1007/s10875-020-00789-4] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 7.0] [Reference Citation Analysis]
|
| 9 |
Yan WL, Yang SL, Zhao FY, Xu XJ. Ruxolitinib is an alternative to etoposide for patient with hemophagocytic lymphohistiocytosis complicated by acute renal injury: A case report. J Oncol Pharm Pract 2021;:10781552211020821. [PMID: 34074166 DOI: 10.1177/10781552211020821] [Reference Citation Analysis]
|
| 10 |
Cupit-Link MC, Kohorst MA, Tran CL, Bleesing JJ, Galardy PJ, Boyce TG. Suspected thrombotic microangiopathy in a child with Epstein-Barr virus-induced hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2018;65:e27002. [PMID: 29411928 DOI: 10.1002/pbc.27002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
|
